NF-κB Inhibitor, SN50
-
Catalog number2506-1000
-
PricePlease ask
-
Size1 mg
-
-
Alternative_nameSN50; AAVALLPAVLLALLAPVQRKRQKLMP
-
DescriptionThis peptide contains the nuclear localization sequence (NLS residues 360-369) of the transcription factor NF-κB p50 linked to a peptide cell-permeablization sequence, the hydrophobic region (h-region) of the signal peptide of Kaposi fibroblast growth factor (K-FGF). SN50 inhibits translocation of the NF-κB active complex into the nucleus. In mouse endothelial LE-II cells induced with LPS, inhibition of NF-κB nuclear translocation was 88% at 50 µg/ml (18 µM). In human monocytic THP-1 cells induced by LPS or TNFα there was 85% inhibition at 100 µg/ml.
-
CAS Number213546-53-3
-
Structure AvailableNo
-
Peptide sequenceAla-Ala-Val-Ala-Leu-Leu-Pro-Ala-Val-Leu-Leu-Ala-Leu-Leu-Ala-Pro-Val-Gln-Arg-Lys-Arg-Gln-Lys-Leu-Met-Pro-OH
-
Salt FormTFA salt
-
Molecular FormulaC₁₂₉H₂₃₀N₃₆O₂₉S
-
Molecular Weight2781.5
-
Cell PermeableYes
-
Purity≥97% by HPLC
-
SolubilitiesH₂O
-
HandlingProtect from air and moisture
-
Tag LineA NF-κB Inhibitor
-
Storage Condition-20°C
-
Shipping ConditionGel pack
-
Shelf Life24 months
-
SMILESN/A
-
InChiN/A
-
InChi KeyN/A
-
MSDS AvailableYes
-
Additional descriptionTissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
-
Gene target
-
Short nameNF-κB Inhibitor, SN50
-
Alternative nameNF-κB suppressor, SN50
-